Disease | small cell carcinoma |
Symptom | C0153690|bone metastasis |
Sentences | 12 |
PubMedID- 26276360 | Skeletal-related events (sres) for nonsmall cell lung cancer (nsclc) patients with bone metastasis lead to serious morbidity. |
PubMedID- 22729551 | Comparison of diagnostic ability between (99m)tc-mdp bone scan and (18)f-fdg pet/ct for bone metastasis in patients with small cell lung cancer. |
PubMedID- 22679429 | Among clinical studies, a phase iii study indicated that zoledronic acid decreased sres due to bone metastasis of non-small cell lung cancer (nsclc) 2. |
PubMedID- 20608863 | A 60-year-old male patient suffering from a non-small cell lung cancer with bone metastasis was under treatment with docetaxel and developed acral erythema involving photoexposed areas. |
PubMedID- 19285820 | bone metastasis in patients with non-small cell lung cancer: the diagnostic role of f-18 fdg pet/ct. |
PubMedID- 26143039 | Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer. |
PubMedID- 25738754 | Therefore, tcn may be a novel agent for treatment of nonsmall cell lung cancer patients with bone metastasis. |
PubMedID- 22672969 | Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. |
PubMedID- 22158485 | Methods and study design: eighteen patients having non-small cell lung cancer (nsclc) with bone metastasis who received carboplatin/nedaplatin plus paclitaxel combined with zol (4 mg every 28 days) were enrolled to investigate the feasibility of this treatment. |
PubMedID- 20422345 | Conversely, cytoplasmic staining of tumor cells was observed in small cell lung cancer tissues with non-bone metastasis. |
PubMedID- 26166822 | Xcr1 promotes cell growth and migration and is correlated with bone metastasis in non-small cell lung cancer. |
PubMedID- 20932965 | Serum tartrate-resistant acid phosphatase 5b (tracp5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients. |
Page: 1